Recursion uses artificial intelligence to help advance drug discovery, which could be a massive opportunity in healthcare.
Indonesian auteur Kamila Andini's latest project 'Four Seasons in Java' won two prizes at the inaugural Tokyo Gap-Financing ...
Excavated with colonial labor and shipped to the Netherlands, the famous fossil is being repatriated to Indonesia along with ...
Abstract: In Part II, both skin and proximity effects in multisolid and hollow conductor arrays are accurately predicted over an ultrawide frequency range. This is accomplished through the development ...
Abstract: Multi-modal image synthesis is crucial for obtaining complete modalities due to the imaging restrictions in reality. Current methods, primarily CNN-based models, find it challenging to ...
Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...
In the latest close session, Recursion Pharmaceuticals (RXRX) was down 5.42% at $5.23. The stock fell short of the S&P 500, which registered a loss of 0.38% for the day. Meanwhile, the Dow experienced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback